Search Results - Wilbert Van Duijnhoven
- Showing 1 - 1 results of 1
-
1
Safety and immunogenicity of heterologous Ad26.ZEBOV and MVA-BN®-Filo prime-boost Ebola vaccines: 6-month follow-up of a Phase I randomized trial in healthy adults by Macaya Douoguih, Neil Goldstein, Stephan Bart, Kerstin Luhn, Wilbert Van Duijnhoven, Carla Truyers, Benoit Callendret
Published 2016Call Number: Loading…Connect to this object online.
Located: Loading…
Book